Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Spectrum Pharmaceuticals, Inc. - Common Stock (NQ: SPPI )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Spectrum Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Why Clovis Oncology Is Trading Higher By 14%; Here Are 28 Stocks Moving Premarket
Gainers Aditxt, Inc. (NASDAQ: ADTX) rose 46.1% to $0.2801 in pre-market trading after jumping 37% on Friday. 
Via Benzinga
Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at ESMO Congress 2022
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
SPECTRUM PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Spectrum Pharmaceuticals, Inc. - SPPI
From Kahn Swick & Foti, LLC
Via Business Wire
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
Via Benzinga
Spectrum Gets FDA Nod For Febrile Neutropenia Candidate, Sees Commercial Launch In Q4 2022
The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ: SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as... 
Via Benzinga
Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON™ (eflapegrastim-xnst) Injection
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning! It's time for another overview of the biggest pre-market stock movers as we see what's happening on Thursday! 
Via InvestorPlace
Spectrum Pharmaceuticals Announces Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at the Upcoming ESMO Congress 2022
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar. 
Via Benzinga
SPECTRUM PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Spectrum Pharmaceuticals, Inc. - SPPI
From Kahn Swick & Foti, LLC
Via Business Wire
Spectrum Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update
From Spectrum Pharmaceuticals
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals to Present Data at 2022 ASCO Highlighting the Potential Predictive Capabilities of ctDNA as a Biomarker for Poziotinib Treatment Response
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals to Participate in H.C. Wainwright Global Investment Conference
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals: Q1 Earnings Insights
Spectrum Pharmaceuticals (NASDAQ:SPPI) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Spectrum Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Spectrum Pharmaceuticals's Earnings Outlook
Spectrum Pharmaceuticals (NASDAQ:SPPI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Earnings Scheduled For May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter. 
Via Benzinga
Spectrum Pharmaceuticals Appoints Nora E. Brennan as Chief Financial Officer
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals to Report First Quarter 2022 Financial Results and Provide Corporate Update
From Spectrum Pharmaceuticals
Via Business Wire
Spectrum Pharmaceuticals Appoints Brittany K. Bradrick to Board of Directors
From Spectrum Pharmaceuticals
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Cyngn Inc. (NASDAQ: CYN) shares jumped 96.3% to close at $2.12 on Thursday after the company announced the official launch of DriveMod Kit, a turnkey autonomous vehicle... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Rise and shine, investor! It's time to start off another week of trading with the biggest pre-market stock movers for Monday! 
Via InvestorPlace
Spectrum Pharmaceuticals Announces FDA Acceptance of BLA Resubmission for Eflapegrastim
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.